⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDGL News
Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
NASH/MASH Treatment Market to Surpass USD 31.76 Billion by 2033 as First-in-Class Drugs Redefine Fatty Liver Disease Management | According to DataM Intelligence
prnewswire.com
MDGL
AKRO
BTRX
SAGM
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
globenewswire.com
MDGL
Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates
globenewswire.com
MDGL
Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL